Relay Therapeutics (RLAY) Amortizatization of Intangibles (2019 - 2026)

Relay Therapeutics' (RLAY) quarterly Amortizatization of Intangibles came in at $782000.0 in Q1 2026, down 51.03% year-on-year from $1.6 million in Q1 2025, and down 8.75% on a QoQ basis from $857000.0 in Q4 2025.

Relay Therapeutics (RLAY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Relay Therapeutics (RLAY) has 8 years of Amortizatization of Intangibles data on file, last reported at $782000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 51.03% year-over-year to $782000.0 in Q1 2026; TTM through Mar 2026 was $4.1 million, a 59.66% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 59.81% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $782000.0, down from $857000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for RLAY reached as high as $3.7 million in Q4 2023 and fell as low as -$681000.0 in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $1.6 million across 5 years, with a median of $1.6 million in 2025.
  • Across the five-year window, Amortizatization of Intangibles tumbled 345.1% in 2022 and jumped 945.88% in 2023, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $385000.0 in 2022, then soared by 852.99% to $3.7 million in 2023, then plunged by 40.56% to $2.2 million in 2024, then tumbled by 60.71% to $857000.0 in 2025, then dropped by 8.75% to $782000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $782000.0 in Q1 2026, $857000.0 in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Relay Therapeutics 3.35 Bn 3.35 Bn - 782,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 782,000.00
Mar 31, 2026 782,000.00
Dec 31, 2025 857,000.00
Dec 31, 2025 857,000.00
Sep 30, 2025 1.10 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.39 Mn
Jun 30, 2025 1.39 Mn
Mar 31, 2025 1.60 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 2.18 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 3.18 Mn
Sep 30, 2024 3.18 Mn
Jun 30, 2024 3.29 Mn
Jun 30, 2024 3.29 Mn
Mar 31, 2024 3.67 Mn
Mar 31, 2024 3.67 Mn
Dec 31, 2023 3.67 Mn
Dec 31, 2023 3.67 Mn